- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Opinion
Video
Implementing Photodynamic Therapy to Improve Patient Outcomes
Author(s):
Key Takeaways
- PDT has demonstrated efficacy in treating non-melanoma skin cancers, esophageal cancer, and certain lung cancers.
- A patient with early-stage esophageal cancer achieved complete remission after undergoing PDT.
Anthony M. Rossi, MD, highlights a successful case of photodynamic therapy (PDT), provides background on the patient’s outcome, and explains how increased use of PDT can enhance patient satisfaction and improve practice outcomes.
Video Player is loading.
Video content above is prompted by the following:
- Do you have a specific example to share of a successful use of PDT and background on that patient success?
- How can the increased use of PDT impact patient satisfaction and practice outcomes?
Related Videos
Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies
Key Considerations for Evaluating Ruxolitinib Cream as a Treatment for Young Children
Supporting Caregivers in Successful Long-Term Atopic Dermatitis Management: The Role of Dermatologists
Challenges and Emerging Solutions in Treatment for Age Groups: Addressing Disease Control, Safety, and Usability
Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma
Differentiating Between JAK Inhibitors in Clinical Practice
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
Clinical Attributes of IL-17 Inhibitors in Psoriasis
Laboratory Monitoring with Oral JAK Inhibitors
Related Content
